Is a complete RDY research report available?

No complete published report is available for Dr. Reddy's Laboratories Limited (RDY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · USD

$14.1

+0.39 (+2.9%)· Recorded snapshot

Market cap	12B
Revenue (ttm)	3.4B
Net income (ttm)	291.9M
EPS (ttm)	$0.35
Shares out	833.1M
P/E (trailing)	40.1x
P/E (forward)	25.7x
Dividend	$0.06 (0.46%)
Volume	3,099,340
Beta	0.25

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001135951
Company name	Dr. Reddy's Laboratories Limited
Country	India
Country code	US
CUSIP number	256135203
Earnings date	2026-10-23
Earnings time	bmo
Employees	27,527
Employees change	-284
Employees growth	-1.02%
Enterprise value	$12B
Exchange	NYSE
Financial currency	INR
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	March
Founded	1984
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
Is SPAC	No
ISIN number	US2561352038
Last 10-K release date	2026-05-29
Last earnings date	2026-10-23
Last refreshed	2026-10-28
Last stock split date	2024-11-05
Last stock split type	Forward
Market cap	$12B
Market cap category	Large-Cap
Next earnings date	2027-01-19
Options	Yes
Price	$14.15
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RDY
Website	https://www.drreddys.com

Metric

Value

Amount currency

USD

CIK code

0001135951

Company name

Dr. Reddy's Laboratories Limited

Country

India

Country code

CUSIP number

256135203

Earnings date

2026-10-23

Earnings time

bmo

Employees

27,527

Employees change

-284

Employees growth

-1.02%

Enterprise value

$12B

Exchange

NYSE

Financial currency

INR

Financial report date

2026-09-30

First seen

2026-05-09

Fiscal year end

March

Founded

1984

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Is SPAC

ISIN number

US2561352038

Last 10-K release date

2026-05-29

Last earnings date

2026-10-23

Last refreshed

2026-10-28

Last stock split date

2024-11-05

Last stock split type

Forward

Market cap

$12B

Market cap category

Large-Cap

Next earnings date

2027-01-19

Options

Yes

Price

$14.15

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

RDY

Website

https://www.drreddys.com

Metric	Value
Adjusted P/E ratio	36.32x
Average P/E ratio (10Y)	28.75x
Average P/E ratio (3Y)	22.15x
Average P/E ratio (5Y)	22.38x
Earnings yield	2.49%
EV/Earnings	39.99x
EV/EBIT	37.23x
EV/EBITDA	22.48x
EV/FCF	80.32x
EV/Sales	3.39x
FCF / EV yield	1.24%
FCF yield	1.24%
Forward EV/Sales	2.94x
Forward P/E	25.66x
Forward P/S	2.95x
Graham number	6.23377
Graham upside	-55.79%
Industry forward P/E	13.59x
Industry P/E	175.96x
Lynch fair value	$2.66
Lynch upside	-81.14%
P/(FCF - SBC) ratio	82.22x
P/(OCF - SBC) ratio	36.36x
P/B ratio	2.88x
P/E ratio	40.12x
P/FCF ratio	80.38x
P/OCF ratio	35.99x
P/S ratio	3.4x
Price / tangible book value	4.16x
Price/EBITDA ratio	22.49x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

36.32x

Average P/E ratio (10Y)

28.75x

Average P/E ratio (3Y)

22.15x

Average P/E ratio (5Y)

22.38x

Earnings yield

2.49%

EV/Earnings

39.99x

EV/EBIT

37.23x

EV/EBITDA

22.48x

EV/FCF

80.32x

EV/Sales

3.39x

FCF / EV yield

1.24%

FCF yield

1.24%

Forward EV/Sales

2.94x

Forward P/E

25.66x

Forward P/S

2.95x

Graham number

6.23377

Graham upside

-55.79%

Industry forward P/E

13.59x

Industry P/E

175.96x

Lynch fair value

$2.66

Lynch upside

-81.14%

P/(FCF - SBC) ratio

82.22x

P/(OCF - SBC) ratio

36.36x

P/B ratio

2.88x

P/E ratio

40.12x

P/FCF ratio

80.38x

P/OCF ratio

35.99x

P/S ratio

3.4x

Price / tangible book value

4.16x

Price/EBITDA ratio

22.49x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	9.11%
EBITDA margin	15.1%
Effective tax rate	21.69%
FCF margin	4.2%
Gross margin	49.49%
Operating margin	9.11%
Pretax margin	10.68%
Profit margin	8.48%
Profit per employee	$10,603
Profitable years	17
Revenue per employee	$124,971
ROA	3.37%
ROA (5Y)	9.28%
ROCE	7.16%
ROE	7.34%
ROE (5Y)	17.3%
ROIC	6.17%
ROIC (5Y)	18.57%
SBC / revenue	0.09%
Tax / revenue	2.32%

Metric

Value

EBIT margin

9.11%

EBITDA margin

15.1%

Effective tax rate

21.69%

FCF margin

4.2%

Gross margin

49.49%

Operating margin

9.11%

Pretax margin

10.68%

Profit margin

8.48%

Profit per employee

$10,603

Profitable years

Revenue per employee

$124,971

ROA

3.37%

ROA (5Y)

9.28%

ROCE

7.16%

ROE

7.34%

ROE (5Y)

17.3%

ROIC

6.17%

ROIC (5Y)

18.57%

SBC / revenue

0.09%

Tax / revenue

2.32%

Metric	Value
EPS growth	-52.23%
EPS growth (Q)	-35.65%
EPS growth (QoQ)	108.65%
EPS growth 10Y	10.23%
EPS growth 3Y	-18.09%
EPS growth 5Y	7.5%
EPS growth years	0
FCF growth	-56.58%
FCF growth (Q)	-72.14%
FCF growth 3Y	-38.42%
FCF growth 5Y	24.27%
Gross profit growth	-15.46%
Gross profit growth (Q)	-6.1%
Gross profit growth 3Y	1.52%
Gross profit growth 5Y	8.53%
Net income growth	-52.26%
Net income growth (Q)	-35.64%
Net income growth (QoQ)	108.57%
Net income growth 3Y	-18.07%
Net income growth 5Y	7.55%
Net income growth years	0
OCF growth	-47.45%
OCF growth (Q)	-66.07%
OCF growth 10Y	0.63%
OCF growth 3Y	-24.6%
OCF growth 5Y	12.45%
Operating income growth	-57.92%
Operating income growth (Q)	-28.53%
Operating income growth 3Y	-22.35%
Operating income growth 5Y	-2.03%
Revenue growth	-3.6%
Revenue growth (Q)	-1.53%
Revenue growth (QoQ)	7.44%
Revenue growth 10Y	8.63%
Revenue growth 3Y	7.32%
Revenue growth 5Y	10.15%
Revenue growth years	9

Metric

Value

EPS growth

-52.23%

EPS growth (Q)

-35.65%

EPS growth (QoQ)

108.65%

EPS growth 10Y

10.23%

EPS growth 3Y

-18.09%

EPS growth 5Y

7.5%

EPS growth years

FCF growth

-56.58%

FCF growth (Q)

-72.14%

FCF growth 3Y

-38.42%

FCF growth 5Y

24.27%

Gross profit growth

-15.46%

Gross profit growth (Q)

-6.1%

Gross profit growth 3Y

1.52%

Gross profit growth 5Y

8.53%

Net income growth

-52.26%

Net income growth (Q)

-35.64%

Net income growth (QoQ)

108.57%

Net income growth 3Y

-18.07%

Net income growth 5Y

7.55%

Net income growth years

OCF growth

-47.45%

OCF growth (Q)

-66.07%

OCF growth 10Y

0.63%

OCF growth 3Y

-24.6%

OCF growth 5Y

12.45%

Operating income growth

-57.92%

Operating income growth (Q)

-28.53%

Operating income growth 3Y

-22.35%

Operating income growth 5Y

-2.03%

Revenue growth

-3.6%

Revenue growth (Q)

-1.53%

Revenue growth (QoQ)

7.44%

Revenue growth 10Y

8.63%

Revenue growth 3Y

7.32%

Revenue growth 5Y

10.15%

Revenue growth years

Metric	Value
Capital expenditures	$-179.2M
Depreciation and amortization	$207.1M
EBIT	$313.6M
EBITDA	$519.3M
EPS	$0.35
FCF per share	$0.17
Financing cash flow	$1.4M
Free cash flow	$145.3M
Free cash flow minus SBC	$142.1M
Gross profit	$1.7B
Income taxes	$79.7M
Investing cash flow	$-298.9M
Net borrowing	$118.9M
Net cash flow	$34.3M
Net income	$291.9M
Operating cash flow minus SBC	$321.3M
Operating income	$313.6M
Revenue	$3.4B
Stock-based compensation	$3.2M

Metric

Value

Capital expenditures

$-179.2M

Depreciation and amortization

$207.1M

EBIT

$313.6M

EBITDA

$519.3M

EPS

$0.35

FCF per share

$0.17

Financing cash flow

$1.4M

Free cash flow

$145.3M

Free cash flow minus SBC

$142.1M

Gross profit

$1.7B

Income taxes

$79.7M

Investing cash flow

$-298.9M

Net borrowing

$118.9M

Net cash flow

$34.3M

Net income

$291.9M

Operating cash flow minus SBC

$321.3M

Operating income

$313.6M

Revenue

$3.4B

Stock-based compensation

$3.2M

Metric	Value
Altman Z-Score	5.29
Book value per share	$4.83
Debt / EBITDA	1.4
Debt / equity	0.19
Debt / FCF	5.19
Goodwill	$136.3M
Interest coverage	6.67
Long-term assets	$2.9B
Long-term liabilities	$308.6M
Net cash (debt)	$41.2M
Net cash / market cap	0.35%
Net cash growth	-64.92%
Net debt / EBITDA	-0.08
Net debt / equity	-0.01
Net debt / FCF	-0.28
Piotroski F-Score	5
Property, plant and equipment	$1.2B
Shareholders' equity	$4.1B
Tangible book value	$2.8B
Tangible book value per share	$3.37
Total assets	$6B
Total cash	$795.2M
Total debt	$753.9M
Total liabilities	$1.9B
WACC	5.58%

Metric

Value

Altman Z-Score

5.29

Book value per share

$4.83

Debt / EBITDA

1.4

Debt / equity

0.19

Debt / FCF

5.19

Goodwill

$136.3M

Interest coverage

6.67

Long-term assets

$2.9B

Long-term liabilities

$308.6M

Net cash (debt)

$41.2M

Net cash / market cap

0.35%

Net cash growth

-64.92%

Net debt / EBITDA

-0.08

Net debt / equity

-0.01

Net debt / FCF

-0.28

Piotroski F-Score

Property, plant and equipment

$1.2B

Shareholders' equity

$4.1B

Tangible book value

$2.8B

Tangible book value per share

$3.37

Total assets

$6B

Total cash

$795.2M

Total debt

$753.9M

Total liabilities

$1.9B

WACC

5.58%

Metric	Value
Asset turnover	0.59
Current assets	$3.1B
Current liabilities	$1.6B
Current ratio	1.93
Inventory turnover	2.12
Net working capital	$1.3B
Quick ratio	1.15
Working capital	$1.5B
Working capital turnover	0.03

Metric

Value

Asset turnover

0.59

Current assets

$3.1B

Current liabilities

$1.6B

Current ratio

1.93

Inventory turnover

2.12

Net working capital

$1.3B

Quick ratio

1.15

Working capital

$1.5B

Working capital turnover

0.03

Metric	Value
Buyback yield / dilution	0.05%
Dividend growth	-10.07%
Dividend growth (10Y)	1.41%
Dividend growth (3Y)	-7.78%
Dividend growth (5Y)	2.82%
Dividend growth years	0
Dividend payment date	2026-08-05
Dividend payment years	26
Dividend payout frequency	Annual
Dividend per share	$0.06
Dividend yield	0.46%
Ex-dividend date	2026-07-24
FCF payout ratio	23.74%
Last dividend	$0.06
Payout ratio	15.29%
Shareholder yield	0.51%

Metric

Value

Buyback yield / dilution

0.05%

Dividend growth

-10.07%

Dividend growth (10Y)

1.41%

Dividend growth (3Y)

-7.78%

Dividend growth (5Y)

2.82%

Dividend growth years

Dividend payment date

2026-08-05

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

$0.06

Dividend yield

0.46%

Ex-dividend date

2026-07-24

FCF payout ratio

23.74%

Last dividend

$0.06

Payout ratio

15.29%

Shareholder yield

0.51%

Metric	Value
10Y price change	42.6%
10Y return CAGR	4.22%
10Y total return	51.19%
150-day SMA	$12.95
15Y price change	108.59%
15Y return CAGR	5.65%
15Y total return	128%
1D price change	2.87%
1M price change	14.94%
1M total return	14.94%
1W price change	6.18%
1W total return	6.18%
1Y price change	-2.7%
1Y return CAGR	-2.16%
1Y total return	-2.16%
20-day SMA	$12.91
200-day SMA	$13.21
20Y price change	312.18%
20Y return CAGR	8.08%
20Y total return	372.67%
3M price change	19.63%
3M total return	19.63%
3Y price change	8.22%
3Y return CAGR	3.19%
3Y total return	9.89%
50-day SMA	$12.46
50-day SMA vs 200-day SMA	50under200
52-week high	$15.67
52-week high date	2026-06-26
52-week low	$11.36
52-week low date	2026-07-22
5Y price change	14.83%
5Y return CAGR	3.37%
5Y total return	18.03%
6M price change	0.79%
6M total return	1.34%
All-time high	$16.89
All-time high date	2024-08-09
All-time low	$1.00
All-time low date	2001-04-11
Average true range (ATR)	$0.31
Average volume	3.1M
Beta (5Y)	0.25
Change from 52-week high	-9.73%
Change from 52-week low	24.52%
Change from all-time high	-16.65%
Change from all-time low	1,302.39%
Change from open	1.91%
Day's gap	0.95%
Dollar volume	$43.8M
High price	$14.23
Low price	$13.69
Monthly RSI	52.28
Open price	$13.88
Position in 52-week range	84.26%
Premarket change	0.44%
Premarket close	$13.75
Premarket price	$13.81
Premarket volume	18.8K
Previous close	$13.75
Price vs 150-day SMA	8.76%
Price vs 20-day SMA	9.1%
Price vs 200-day SMA	6.63%
Price vs 50-day SMA	13.02%
Relative volume	1.01
RSI	77.78
Sharpe ratio	-0.08
Sharpe ratio (3Y)	0.06
Sharpe ratio (5Y)	0.07
Sortino ratio	0.08
Sortino ratio (3Y)	0.3
Sortino ratio (5Y)	0.32
Volume	3.1M
Weekly RSI	62.47
YTD price change	0.28%
YTD total return	0.83%

Metric

Value

10Y price change

42.6%

10Y return CAGR

4.22%

10Y total return

51.19%

150-day SMA

$12.95

15Y price change

108.59%

15Y return CAGR

5.65%

15Y total return

128%

1D price change

2.87%

1M price change

14.94%

1M total return

14.94%

1W price change

6.18%

1W total return

6.18%

1Y price change

-2.7%

1Y return CAGR

-2.16%

1Y total return

-2.16%

20-day SMA

$12.91

200-day SMA

$13.21

20Y price change

312.18%

20Y return CAGR

8.08%

20Y total return

372.67%

3M price change

19.63%

3M total return

19.63%

3Y price change

8.22%

3Y return CAGR

3.19%

3Y total return

9.89%

50-day SMA

$12.46

50-day SMA vs 200-day SMA

50under200

52-week high

$15.67

52-week high date

2026-06-26

52-week low

$11.36

52-week low date

2026-07-22

5Y price change

14.83%

5Y return CAGR

3.37%

5Y total return

18.03%

6M price change

0.79%

6M total return

1.34%

All-time high

$16.89

All-time high date

2024-08-09

All-time low

$1.00

All-time low date

2001-04-11

Average true range (ATR)

$0.31

Average volume

3.1M

Beta (5Y)

0.25

Change from 52-week high

-9.73%

Change from 52-week low

24.52%

Change from all-time high

-16.65%

Change from all-time low

1,302.39%

Change from open

1.91%

Day's gap

0.95%

Dollar volume

$43.8M

High price

$14.23

Low price

$13.69

Monthly RSI

52.28

Open price

$13.88

Position in 52-week range

84.26%

Premarket change

0.44%

Premarket close

$13.75

Premarket price

$13.81

Premarket volume

18.8K

Previous close

$13.75

Price vs 150-day SMA

8.76%

Price vs 20-day SMA

9.1%

Price vs 200-day SMA

6.63%

Price vs 50-day SMA

13.02%

Relative volume

1.01

RSI

77.78

Sharpe ratio

-0.08

Sharpe ratio (3Y)

0.06

Sharpe ratio (5Y)

0.07

Sortino ratio

0.08

Sortino ratio (3Y)

0.3

Sortino ratio (5Y)

0.32

Volume

3.1M

Weekly RSI

62.47

YTD price change

0.28%

YTD total return

0.83%

Metric	Value
Float	600.1M
Float percentage	72.03%
Shares change (QoQ)	-0.04%
Shares change (YoY)	-0.05%
Shares held by insiders	26.72%
Shares held by institutions	57.63%
Shares outstanding	833.1M
Short % of shares	4.14%
Short ratio	9 days

Metric

Value

Float

600.1M

Float percentage

72.03%

Shares change (QoQ)

-0.04%

Shares change (YoY)

-0.05%

Shares held by insiders

26.72%

Shares held by institutions

57.63%

Shares outstanding

833.1M

Short % of shares

4.14%

Short ratio

9 days

Dr. Reddy's Laboratories Limited (RDY)

Price

Financial snapshot

Fair-value bridge

Latest news · RDY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RDY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RDY

Frequently asked questions